Trial Profile
A trial of tocilizumab for the treatment of refractory non-infectious aortitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Aortitis
- Focus Therapeutic Use
- 04 Feb 2016 New trial record